Clinical Trial: Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects
Study Status: Completed
Recruit Status: RECRUITING
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: A Double-Blind, Randomized, Placebo-Controlled, First-in-Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered DF-003 Following Single (Part 1) and Multiple (Pa
Brief Summary:
The goal of this clinical trial is to evaluate the safety, tolerability, and pharmacokinetics (PK; drug metabolism) of DF-003 after oral administration of single and multiple ascending doses in healthy subjects.The choice of using healthy subjects is standard in establishing the preliminary safety and PK profile of a drug.DF-003 is a potent small molecule inhibitor of alpha-kinase 1 (ALPK1), which plays an important role in immunity and inflammation.DF-003 can inhibit the immune inflammatory response and has been…
Read more